ADARx Pharmaceuticals, Inc. (ADRX)
NMS · Healthcare · Biotechnology
$17.78
+0.57%
Closing price as of 2026-10-09 · Source: TEK2day Finance
Key Metrics
Market Cap
$1.90B
Shares Outstanding
106.8M
P/S (TTM)
614x
Exchange
NMS
Currency
USD
Quarterly Financials
| Metric | 2025-03-31 | 2025-06-30 | 2026-03-31 | 2026-06-30 |
|---|---|---|---|---|
| Revenue | 0.00 | 208K | 2.1M | 746K |
| Operating Income | (17.9M) | (21.1M) | (27.1M) | (29.9M) |
| Net Income | (15.6M) | (18.1M) | (22.7M) | (25.8M) |
| Diluted EPS | $-0.21 | N/A | $-0.22 | N/A |
Annual Financials
| Metric | 2024-12-31 | 2025-12-31 |
|---|---|---|
| Revenue | 0.00 | 3.4M |
| Operating Income | (58.2M) | (88.4M) |
| Net Income | (46.4M) | (73.1M) |
| Diluted EPS | $-0.62 | $-0.97 |